Immix Biopharma (IMMX) announced that it has received a strategic investment from Goose Capital and former Tanox, Inc. CEO Nancy Chang, Goose founding member. At Tanox, Chang and her team invented and developed FDA-approved Xolair for severe asthma, Trogarzo for HIV, and Ebglyss for dermatitis, collectively generating drug sales exceeding $5B dollars so far.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMMX: